{"id":14712,"date":"2019-02-05T15:50:26","date_gmt":"2019-02-05T14:50:26","guid":{"rendered":"https:\/\/www.andrewalliance.com\/?p=14712"},"modified":"2022-10-03T02:17:16","modified_gmt":"2022-10-03T00:17:16","slug":"andrew-alliance-sa-and-valitacell-ltd-collaborate-to-automate-critical-aspects-of-cell-line-development","status":"publish","type":"post","link":"https:\/\/www.andrewalliance.com\/fr\/press\/andrew-alliance-sa-and-valitacell-ltd-collaborate-to-automate-critical-aspects-of-cell-line-development\/","title":{"rendered":"Andrew Alliance and Valitacell Collaborate to Automate Cell Line Development"},"content":{"rendered":"

Andrew Alliance S.A<\/span>.<\/a>, the robotics company that is improving laboratory workflow execution through the development of a cloud-based software solution (OneLab) together with connected devices, and biotechnology company, Valitacell Ltd., today announced a collaboration agreement to integrate Valitacell’s cell line development applications into OneLab. This exciting partnership will combine Valitacell’s novel analytical technologies with\u00a0Andrew Alliance’s<\/span>connected devices, and will have a transformative impact on the manufacture of biologic drugs. Valitacell’s intelligent analytical technologies enable data driven decisions which, combined with automation and connectivity, will help streamline the biomanufacturing industries’ processes, to improve manufacturing productivity, speed-up time to market and reduce the cost of goods overall.<\/p>\n

“Developing cell lines, reagents and protocols for manufacturing biopharmaceuticals is a lengthy and complex process,” said\u00a0Piero Zucchelli<\/span>, CEO and co-founder of\u00a0Andrew Alliance<\/span>. “Valitacell have innovative technologies that are extremely suitable for automation, and by combining our two companies’ core competencies, we will be able to bring exciting solutions to this market which will simplify things greatly.”<\/p>\n

“Automation of the drug discovery and development process combined with Valitacell’s smart analytics provides a disruptive solution to addresses the challenges faced by the biopharmaceutical industry. We are delighted to collaborate with\u00a0Andrew Alliance<\/span>\u00a0to bring these innovative new solutions to our customers,” said Dr\u00a0Terry McWade<\/span>, CEO and co-founder of Valitacell. “This collaboration reflects both companies’ commitment to providing scientists with the tools they need to efficiently optimize their laboratory processes and make intelligent, data driven decisions during the drug development process.”<\/p>\n

About\u00a0Andrew Alliance<\/span><\/b>\u00a0
Andrew Alliance<\/span>\u00a0is advancing science with a new class of high-performance, easy-to-use robots that dramatically improve the repeatability, performance and speed of liquid handling. This new approach, and Andrew, the flagship robot, are winning awards and rapidly transforming bench research in hundreds of pharmaceutical, diagnostic and academic laboratories worldwide, by eliminating routine pipetting errors and time-consuming manual efforts. Visit\u00a0andrewalliance.com<\/a>\u00a0to see how it works.<\/p>\n

About\u00a0<\/b>Valitacell<\/b>\u00a0<\/b>\u00a0
Valitacell is an\u00a0Ireland<\/span>\u00a0based biotechnology company accelerating the development of life-saving medicines with a suite of novel, intelligent analytical technology platforms, engineered to provide process control in cell-based manufacturing to achieve the highest levels of bioprocess performance. The flagship product Valita\u00aeTITER provides a simple and rapid protein quantification, and Valita\u00aePROFILE is a novel cell profiling tool for the deep assessment of cellular function. Visit\u00a0http:\/\/www.valitacell.com<\/a>\u00a0for more information.<\/p>\n

SOURCE Andrew Alliance SA<\/p>\n

Biologic drugs are precision medicines which have revolutionised the treatment of chronic diseases such as cancer and inflammatory disorders. However, there are significant manufacturing challenges in translating these therapies to the market, due to a complex, time-consuming and labour-intensive manufacturing process.<\/p>","protected":false},"excerpt":{"rendered":"

Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the development of a cloud-based software solution (OneLab) together with connected devices, and biotechnology company, Valitacell Ltd., today announced a collaboration agreement to integrate Valitacell’s cell line development applications into OneLab. This exciting partnership will combine Valitacell’s novel analytical technologies with\u00a0Andrew Alliance’sconnected devices, and will have a transformative impact on the manufacture of biologic drugs. Valitacell’s intelligent analytical technologies enable data driven decisions which, combined with automation and connectivity, will help streamline the biomanufacturing industries’ processes, to improve manufacturing productivity, speed-up time to market and reduce the cost of goods overall.<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-14712","post","type-post","status-publish","format-standard","hentry","category-press"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/14712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/comments?post=14712"}],"version-history":[{"count":0,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/posts\/14712\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/media?parent=14712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/categories?post=14712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.andrewalliance.com\/fr\/wp-json\/wp\/v2\/tags?post=14712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}